Tumor size and the risk for lymph node metastases in T1 esophageal adenocarcinoma. Safety, pharmacokinetics, and efficacy of RC48-ADC in a phase I study in patients with HER2-overexpression advanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback